Literature DB >> 32369612

Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.

Aristeidis Chaidos1,2, Alexia Katsarou1,2, Chira Mustafa1,2, Dragana Milojkovic2, Anastasios Karadimitris1,2.   

Abstract

Entities:  

Keywords:  COVID-19; cytokine release syndrome; interleukin-6; myeloma; tocilizumab

Mesh：

Substances：

Year:  2020        PMID： 32369612     DOI： 10.1111/bjh.16787

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  14 in total

1.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2020-06-27       Impact factor: 9.079

2.  COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.

Authors:  Malin Hultcrantz; Joshua Richter; Cara A Rosenbaum; Dhwani Patel; Eric L Smith; Neha Korde; Sydney X Lu; Sham Mailankody; Urvi A Shah; Alexander M Lesokhin; Hani Hassoun; Carlyn Tan; Francesco Maura; Andriy Derkach; Benjamin Diamond; Adriana Rossi; Roger N Pearse; Deepu Madduri; Ajai Chari; David Kaminetzky; Marc J Braunstein; Christian Gordillo; Ran Reshef; Ying Taur; Faith E Davies; Sundar Jagannath; Ruben Niesvizky; Suzanne Lentzsch; Gareth J Morgan; Ola Landgren
Journal:  Blood Cancer Discov       Date:  2020-07-30

3.  The utility of a local multidisciplinary working group to oversee the establishment of rapidly evolving standards of care and to support trial recruitment during the COVID-19 pandemic.

Authors:  Giovanni Satta; Taryn Youngstein; Liz Lightstone; Mark Gilchrist
Journal:  Clin Med (Lond)       Date:  2021-03-29       Impact factor: 2.659

4.  COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers.

Authors:  Malin Hultcrantz; Joshua Richter; Cara Rosenbaum; Dhwani Patel; Eric Smith; Neha Korde; Sydney Lu; Sham Mailankody; Urvi Shah; Alexander Lesokhin; Hani Hassoun; Carlyn Tan; Francesco Maura; Andriy Derkacs; Benjamin Diamond; Adriana Rossi; Roger N Pearse; Deepu Madduri; Ajai Chari; David Kaminetsky; Marc Braunstein; Christian Gordillo; Faith Davies; Sundar Jagannath; Ruben Niesvizky; Suzanne Lentzsch; Gareth Morgan; Ola Landgren
Journal:  medRxiv       Date:  2020-06-11

Review 5.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

6.  Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

Authors:  Nicola Giesen; Rosanne Sprute; Maria Rüthrich; Yascha Khodamoradi; Sibylle C Mellinghoff; Gernot Beutel; Catherina Lueck; Michael Koldehoff; Marcus Hentrich; Michael Sandherr; Michael von Bergwelt-Baildon; Hans-Heinrich Wolf; Hans H Hirsch; Bernhard Wörmann; Oliver A Cornely; Philipp Köhler; Enrico Schalk; Marie von Lilienfeld-Toal
Journal:  Eur J Cancer       Date:  2020-09-21       Impact factor: 9.162

7.  COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.

Authors:  Jessica J Manson; Colin Crooks; Meena Naja; Amanda Ledlie; Bethan Goulden; Trevor Liddle; Emon Khan; Puja Mehta; Lucia Martin-Gutierrez; Kirsty E Waddington; George A Robinson; Liliana Ribeiro Santos; Eve McLoughlin; Antonia Snell; Christopher Adeney; Ina Schim van der Loeff; Kenneth F Baker; Christopher J A Duncan; Aidan T Hanrath; B Clare Lendrem; Anthony De Soyza; Junjie Peng; Hajar J'Bari; Mandy Greenwood; Ellie Hawkins; Hannah Peckham; Michael Marks; Tommy Rampling; Akish Luintel; Bryan Williams; Michael Brown; Mervyn Singer; Joe West; Elizabeth C Jury; Matthew Collin; Rachel S Tattersall
Journal:  Lancet Rheumatol       Date:  2020-08-21

8.  Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.

Authors:  Andrew J Innes; Lucy B Cook; Sasha Marks; Edward Bataillard; Christina Crossette-Thambiah; Gayathiri Sivasubramaniam; Jane Apperley; Dragana Milojkovic
Journal:  Br J Haematol       Date:  2020-07-26       Impact factor: 8.615

9.  The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma.

Authors:  Hesham Elsabah; Mahmood B Aldapt; Ruba Taha; Dina S Soliman; Halima Elomri; Feryal Ibrahim
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

10.  Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia.

Authors:  Amita Ranger; Ruby Haji; Richard Kaczmarski; Akila Danga
Journal:  Br J Haematol       Date:  2020-06-26       Impact factor: 8.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.